Tulobuterol hydrochloride structure
|
Common Name | Tulobuterol hydrochloride | ||
---|---|---|---|---|
CAS Number | 56776-01-3 | Molecular Weight | 264.191 | |
Density | 1.098 g/cm3 | Boiling Point | 338.2ºC at 760 mmHg | |
Molecular Formula | C12H19Cl2NO | Melting Point | 163ºC | |
MSDS | Chinese USA | Flash Point | 158.3ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Tulobuterol hydrochlorideTulobuterol hydrochloride is a β2-adrenoceptor agonist. |
Name | 2-(tert-Butylamino)-1-(2-chlorophenyl)ethanol hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Tulobuterol hydrochloride is a β2-adrenoceptor agonist. |
---|---|
Related Catalog | |
Target |
β2-adrenoceptor[1] |
In Vitro | Treatment of the cells with Tulobuterol (0.1 μM) significantly decreases the viral titers of RV14 in the supernatants from 12 h after infection compared with the titers in the cells treated with vehicle (0.001% ethanol). Tulobuterol reduces RV14 release in a concentration-dependent manner. Pretreatment of the cells with Tulobuterol reduces the viral titers of RV14 in the supernatants at concentrations of 0.1 μM or greater[2]. |
In Vivo | Tulobuterol, a sympathomimetic drug used as a transdermal patch, increases normal diaphragm muscle strength. In vivo effect of Tulobuterol is examined the on the contractility of diaphragm muscles prepared from mice treated with Endotoxin. In the in vivo treatment, E0 and E4 diaphragm muscles are analyzed at 0, 12, and 24 h after transdermal Tulobuterol treatment. The force-frequency curves of E0 and E4 diaphragm muscles at three time points are not significantly changed each other, indicating that Tulobuterol patch restores the muscle contractility. Thus, diaphragm muscle contractility is maintained during 4 h of Endotoxin administration with Tulobuterol patch for over 24 h[3]. |
Cell Assay | To examine the effects of Tulobuterol, cultured human tracheal epithelial cells from the same donors are treated with either Tulobuterol (0.1 μM) or the vehicle (0.001% ethanol) from 3 days (72 h) before RV14 infection until the end of the experiments after RV14 infection[2]. |
Animal Admin | Mice[3] Experiments are performed on 50 BALB/c mice weighing 21.7±0.2 g, which are divided into 2 groups. In the transdermal Tulobuterol treatment group, a small piece (4×4 mm2) of a 0.5 mg Tulobuterol patch sheet (16×16 mm2) is affxed to the shaved back of each animal and covered with a small adhesive strip. To examine the effect of transdermal Tulobuterol treatment, the diaphragm muscles of mice immediately after E.coli Endotoxin (20 mg/kg) administration are dissected and measured for contractility at 0, 12, and 24 h (n=5 each) after patch affxation, termed T0E0, T12E0, and T24E0, respectively; to examine such effect 4 h after E.coli Endotoxin (20 mg/kg) injection, the diaphragm muscles of another group of mice are dissected and measured for contractility at 0+4,12+4,and 24+4 h (n=5 each) after patch affxation,termed T0E4, T12E4, and T24E4, respectively. |
References |
Density | 1.098 g/cm3 |
---|---|
Boiling Point | 338.2ºC at 760 mmHg |
Melting Point | 163ºC |
Molecular Formula | C12H19Cl2NO |
Molecular Weight | 264.191 |
Flash Point | 158.3ºC |
Exact Mass | 263.084381 |
PSA | 32.26000 |
LogP | 3.95440 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R22 |
RIDADR | NONH for all modes of transport |
RTECS | DN8785000 |
HS Code | 2922199090 |
HS Code | 2922199090 |
---|---|
Summary | 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
[Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment].
Arerugi. 61(6) , 820-31, (2012) Tulobuterol patch (Tulo) is often used for treatment of elder patient with asthma in Japan. However, there is no evidence either ICS plus Tulo or ICS/LABA combination is better for elder patient.Elder... |
|
Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children.
Allergy Asthma Proc. 33(3) , e28-34, (2012) The tulobuterol patch (TP) is a beta(2)-adrenergic agonist with a favorable pharmacokinetic profile used for asthma management in Japan. Because it contains tulobuterol in a molecular, crystallized fo... |
Benzyl alcohol, α-((tert-butylamino)methyl)-o-chloro-, hydrochloride |
1-(2-Chlorophenyl)-2-[(2-methyl-2-propanyl)amino]ethanol hydrochloride (1:1) |
UNII:VNC12181T0 |
2-(tert-butylamino)-1-(2-chlorophenyl)ethanol,hydrochloride |
2-(tert-Butylamino)-1-(2-chlorophenyl)ethanol hydrochloride (1:1) |
α-((tert-Butylamino)methyl)-o-chlorobenzyl alcohol hydrochloride |
α-(tert-Butylamino)methyl-2-chlorobenzyl alcohol hydrochloride |
Tulobuterol hydrochloride |
MFCD00214398 |
Benzenemethanol, 2-chloro-α-[[(1,1-dimethylethyl)amino]methyl]-, hydrochloride (1:1) |
Benzyl alcohol, α-(tert-butylamino)methyl-2-chloro-, hydrochloride |